Elevance Health ELV Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 355.5%-1.8pp | 357.4%-5.5pp | 362.9%-4.7pp | 367.6%-1.9pp | |
| Net margin | 11.7%-2.8pp | 14.6%-0.1pp | 14.7%-1.6pp | 16.3%+0.7pp | |
| Returns | |||||
| Return on equity | 52.6%-10.5pp | 63.1%-2.5pp | 65.6%-3.3pp | 68.9%+8.7pp | |
| Efficiency | |||||
| Asset turnover | 6.5×+0.3× | 6.2×-0.1× | 6.3×+0.2× | 6.1×+0.3× | |
| Liquidity | |||||
| Current ratio | 6×+0.2× | 5.8×+0.1× | 5.7×+0.2× | 5.5×-0.5× | |
| Leverage | |||||
| Debt-to-equity | 2.8×+0.3× | 2.5×-0.2× | 2.7×+0.2× | 2.5×-0.2× | |
| Valuation | |||||
| Market capitalization | $334.18B-26.2% | $452.78B+6.4% | $425.69B-8.3% | $464.02B+21.2% | |
| Price / earnings | 59.4×-11.8× | 71.2×+1.4× | 69.9×-5.9× | 75.8×+0.7× | |
| Price / sales | 1.8×-0.9× | 2.6×+0.1× | 2.6×-0.5× | 3.1×+0.2× | |
| Price / book | 7.7×-3.1× | 10.8×-0.3× | 11.1×-1.8× | 12.9×+2.0× | |
| Dividend yield | 7.4%+2.1pp | 5.3%+0.3pp | 5%+0.9pp | 4.1%-0.3pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Elevance Health's ratios come from?
- Every ratio is computed from Elevance Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
